Ongoing Clinical Trials & Studies

Endo provides required updates around ongoing clinical trials on To access additional detail about these studies please visit the links provided below.

For inquiries about our ongoing clinical trials, please contact us at

Medical Therapeutics

Study ID

Study Description


Study Phase/Type

Recruitment Status* / Identifier (if applicable)
EN2825-226 APHRODITE-1: A Phase 2, Open Label, Self-Controlled Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks in Adult Females. Collagenase clostridium histolyticum EN3835 Phase 2/ Interventional Active, no longer recruiting
New Window


EN3835-108 A Phase 1, Single Blind, Randomized, Placebo Controlled, Dose Escalation Study to Assess the Safety, Effectiveness, and Tolerability of a Single Treatment of EN3835 vs. Placebo for Recalcitrant Plantar Fasciitis. Collagenase clostridium histolyticum EN3835 Phase 1/ Interventional Active, no longer recruiting
EN3835-306 A Multi-Center, Open-Label, Extension Study to Evaluate the Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis. Collagenase clostridium histolyticum EN3835 Phase 3/ Rollover Enrolling by Invitation
New Window


 newWindow_gray.png By clicking on the link(s) on this page you will leave the website and move to an external website(s) independently operated and not managed by Endo Pharmaceuticals. Because Endo Pharmaceuticals does not control the content of the website(s) you are about to visit, and due to its constantly changing nature, we cannot be responsible for its content, accuracy, practices, or standards.

US/RD/CORP/2014/00002a 5/2014